The objective of this systematic review was to assess whether pre-operative brain natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT pro-BNP) are independent predictors of adverse outcomes after cardiac surgery. MEDLINE, Embase and the Cochrane Controlled Trials Register databases were searched. Eligible studies included observational or randomized control trials measuring natriuretic peptide concentrations before induction of anaesthesia for cardiac surgery. Two investigators independently extracted the data and assessed the validity of the included studies. The predictive ability of pre-operative BNP or NT pro-BNP on mortality, post-operative atrial fibrillation (AF) and intra-aortic balloon pump (IABP) requirement was meta-analysed. The association between BNP or NT pro-BNP and other outcomes was systematically summarized. A total of 4933 patients from 22 studies were considered in the systematic review. Ten studies with one or more outcomes of interest were included in the meta-analyses. The strength of association between pre-operative natriuretic peptide levels and adverse outcomes after surgery was variable, as was the size and quality of the included studies. The summary areas under the receiver operating characteristic curve for mortality, post-operative AF and post-operative IABP requirement were 0.61 (95% confidence interval [CI] 0.51-0.70), 0.61 (95% CI 0.58-0.64) and 0.81 (95% CI 0.73-0.89), respectively. With the limited data available, the associations between pre-operative natriuretic peptide levels and adverse outcomes after cardiac surgery were moderate. Future studies should assess whether pre-operative natriuretic peptides can provide additional independent predictive information to well-validated prognostic scores of cardiac surgery.
BACKGROUND
Brain natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT pro-BNP) are synthesized and released by ventricular cardiomyocytes in response to myocardial wall stress and ischaemia [1] . Elevated levels of BNP and NT pro-BNP have been shown to be associated with adverse outcomes in a number of settings, including acute coronary syndrome, congestive heart failure and patients undergoing major non-cardiac surgery [2] [3] [4] .
In patients undergoing cardiac surgery, pre-operative scoring systems such as EuroSCORE have been well validated and are used extensively to predict post-operative risk of death [5] . However, these scoring systems are limited by their complexity, subjective calculation, suboptimal performance in predicting major post-operative morbidity, as well as the potential for deterioration in discrimination and calibration over time, and may not be generalizable to some patient cohorts [6, 7] .
The number of patients undergoing high-risk cardiac surgery is increasing [8] . Accurate risk assessment for cardiac surgery is of paramount importance both for clinical audit and in considering prophylactic interventions to reduce adverse post-operative outcomes [9, 10] .
We hypothesized that BNP and NT pro-BNP are independent predictors of adverse outcomes after adjusting for standard clinical risk factors for cardiac surgery. We conducted a systematic review and meta-analysis to assess the ability of pre-operative BNP or NT pro-BNP in predicting adverse outcomes after cardiac surgery.
MATERIALS AND METHODS

Eligibility criteria
We searched for randomized controlled trials and observational studies in which BNP or NT pro-BNP was measured before the induction of anaesthesia in patients undergoing cardiac surgery. The post-operative outcomes of interest included short-and long-term mortality, post-operative atrial fibrillation (AF), acute myocardial infarction (AMI), cardiogenic shock, requirement for intra-aortic balloon pump (IABP) and intensive care unit (ICU) or hospital length of stay (LOS). Studies in which natriuretic peptide levels were measured only after the induction of anaesthesia were excluded to prevent the potential for the results to be affected by haemodynamic disturbances associated with induction, cardiac canulation and the dilutional effects of cardiopulmonary bypass. Furthermore, by excluding post-induction measurements, the results remain generalizable to a population potentially amenable to pre-operative intervention and optimization. Studies that reported only a composite end-point of all adverse outcomes, or did not include a clearly defined cohort of cardiac surgical patients were also excluded.
Search strategy
The primary electronic search was conducted using MEDLINE, Embase and the Cochrane Central Register of Controlled Trials databases. We used medical subject headings and keyword searches for the terms BNP or N-terminal pro-BNP (NT pro-BNP) combined with medical subject headings and keyword searches for the terms surgery, cardiac surgery, pre-operative, or post-operative. The search included the time period between 1966 and October 2010 and was conducted without language restrictions. We searched the reference lists of all included studies as well as relevant review articles. Where uncertainty existed on study eligibility, the corresponding author was contacted for clarification or to request further information.
Study selection
Both authors screened the results of the search and one author (E.L.) retrieved all potentially relevant articles. Both authors independently applied the inclusion and exclusion criteria, and disagreement was resolved by consensus.
Data extraction and validity appraisal
Both investigators extracted the data and assessed study validity independently; disagreement was resolved by consensus. The outcomes of interest included short-term mortality (≤60 days or in hospital), long-term mortality (>60 days), post-operative AF, AMI, cardiogenic shock, requirement for IABP and ICU or hospital LOS. Assessment of the validity of the observational studies was based on five criteria: whether the study was prospective or retrospective, inclusion of an a priori definition of outcome measures, description of inclusion and exclusion criteria, the completeness of follow-up and assessment of important co-variables in a multivariable analysis.
Data analysis
Sensitivity and specificity of BNP or NT pro-BNP to predict outcomes were extracted from the included studies. Where these data were not directly provided, they were calculated from the data in the reports when feasible. For outcomes in which data were available from more than three studies, pooled diagnostic odds ratios (DORs) and areas under the receiver operating characteristic (ROC) curve were calculated using a fixed-effect model. I 2 was used to quantify heterogeneity, and all calculations were conducted using Meta-DiSc Version 1.4 [11] . 
RESULTS
The initial electronic search returned 819 records. After examination of the titles and abstracts, 90 studies were retrieved for more detailed evaluation. A total of 22 studies including 4933 participants met the inclusion criteria of this systematic review , and 10 studies provided sufficient data for one or more outcomes to be included in the meta-analyses. The flowchart of the search and reasons for study exclusion are presented in Fig. 1 . The sample size of the included studies ranged between 29 and 1519 participants. All the included studies were observational, 16 were prospective, 4 were retrospective and 2 did not report the methodology undertaken. The characteristics of the included studies are described in Table 1 . 1 Details of the assay, cut-off levels and timing are available in the supplementary material.
Study characteristics and validity assessment
There was considerable variation in sample size, natriuretic peptide laboratory test and BNP or NT pro-BNP threshold used in the included studies. Indications for surgery also differed between studies and included patients who had on or off-bypass surgery, elective or emergency surgery for a variety of indications including coronary artery bypass grafting, valve repair or replacement, ventricular reduction and aortic dissection. None of the included studies used an external sample or cohort to validate the diagnostic accuracy of BNP and NT pro-BNP or assessed the calibration of BNP or NT pro-BNP as a prognostic factor. The overall quality of the included studies was only modest and also varied considerably between studies. The results of the validity assessment are shown in Table 2 .
Qualitative data synthesis
Pre-operative BNP and NT pro-BNP were associated with a moderate accuracy in predicting a variety of post-operative adverse events including short-and long-term mortality, AF, cardiogenic shock, IABP requirement, ICU and hospital LOS. The correlation between EuroSCORE and pre-operative natriuretic peptide levels was moderate (r = 0.52-0.66) and did not appear to cause collinearity during the multivariate analysis. In the nine studies (41% of all included studies) in which an appropriate multivariable analysis was performed, the ability of BNP or NT pro-BNP to predict adverse outcomes persisted after adjusting for EuroSCORE or other risk prediction models. The variability in adverse outcomes explained by BNP or NT pro-BNP, as measured by its chi-square contribution in the multivariate models, was not reported in the included studies. No clear differences were apparent between the prognostic ability of BNP and NT pro-BNP. The results for short-term mortality, postoperative AF and post-operative shocked state of all the included studies are summarized in Table 3. 2 Details of any additional outcome measures assessed in each study are available in the supplementary material. Quantitative data synthesis A total of 10 studies reported sufficient and comparable outcome data to provide pooled summary estimates of the association between pre-operative natriuretic peptide levels and postoperative short-term mortality (four studies including 1101 participants), AF (four studies including 1491 participants) and IABP requirement (four studies including 349 participants). The DOR and the area under the ROC curve of BNP and NT pro-BNP to predict short-term mortality were: DOR 1.9 (95% confidence interval [CI] 1.0-3.5) and ROC area 0.61 (95% CI 0.51-0.70, I 2 = 0%), respectively (Table 4 and Fig. 2) . The DOR and the area under the ROC curve to predict post-operative AF were: DOR 1.9 (95% CI 1.6-2.4) and ROC area 0.61 (95% CI 0.55-0.64, I
2 86%), respectively (Table 4 and Fig. 3) . The DOR and the area under the ROC curve to predict post-operative IABP requirement were: DOR 8.3 (95% CI 3.9-17.9) and ROC area 0.81 (95% CI 0.73-0.89, I 2 = 0%), respectively (Table 4 and Fig. 4 ).
DISCUSSION
In this systematic review, all the studies assessing pre-operative BNP or NT pro-BNP to predict outcomes after cardiac surgery were observational in nature and differed considerably in their sample sizes, inclusion criteria and quality. With the limited data available, pre-operative BNP and NT pro-BNP had a moderate ability to discriminate between patients that did and did not have adverse outcomes after cardiac surgery. BNP and NT pro-BNP also appeared to provide prognostic information about the risk of adverse outcomes after cardiac surgery when combined with established risk prediction models such as EuroSCORE. In patients undergoing cardiac surgery, accurate risk adjustment is of paramount importance for clinical audit, benchmarking and research and to identify high-risk patients that may benefit from prophylactic interventions to reduce post-operative adverse outcomes. Our results showed that BNP and NT pro-BNP concentrations had a moderate ability to predict postoperative adverse outcomes and appeared to provide additional prognostic information, especially on the risk of requiring IABP after surgery, which was not fully captured by standard clinical scoring systems such as EuroSCORE [5] . These results require careful consideration. Firstly, BNP and NT pro-BNP are synthesized and released by ventricular cardiomyocytes in response to myocardial wall stress and ischaemia and as such, it is not surprising that they could have an ability to predict a post-operative requirement for IABP. BNP and NT pro-BNP are relatively inexpensive tests, the results are rapidly available, and measurement does not involve subjective assessment. As such, they may be particularly useful in the immediate pre-operative period to stratify patients into different risk categories, or to alert the surgical, anaesthesia and intensive care team that a patient's condition may have changed since previous BNP or NT pro-BNP measurements or after the most recent echocardiography or comprehensive risk assessment.
Secondly, in high-risk patients undergoing cardiac surgery, prophylactic interventions including pre-operative levosimendan and IABP may reduce the incidence of post-operative adverse outcomes [9, 10] . Limitation to widespread adoption of these interventions includes the difficulty in accurately identifying those high-risk patients most likely to benefit. Incorporating BNP or NT pro-BNP as a recruitment criterion or as a baseline characteristic in a randomized controlled trial on effectiveness of a new intervention should be seriously considered, especially if high-risk patients are the targeted participants.
Finally, although many existing clinical prognostic models such as EuroSCORE are very useful, further refinement, update or recalibration are needed to maintain their utility. Most of these clinical prognostic scores for cardiac surgery are only useful in predicting mortality but not adverse events such as AF or cardiogenic shock requiring IABP [6, 7] . Perhaps, incorporating preoperative BNP or NT pro-BNP may improve the performance and generalizability of these prognostic scores and should be seriously considered in the development of new prognostic models for cardiac surgery.
This study has some limitations. Firstly, although we have included all potential studies without language restrictions, there is still a risk of publication bias when investigators do not report their results on outcomes that are negative. Secondly, although the total number of patients considered was not small, the variations in the type of natriuretic peptide assays used, study inclusion criteria and outcomes measured limited the ability to include many studies in the meta-analysis, and hence the precision of the pooled results. Finally, many studies did not report the additive and independent predictive ability of BNP or NT pro-BNP when used with an established risk prediction model, and this merits further investigation and external validation in a large multicentre observational study.
In summary, the strength of associations between preoperative natriuretic peptide levels and adverse outcomes after cardiac surgery varied between different studies. With the limited evidence available from the larger and higher quality studies, pre-operative natriuretic peptide levels were associated with a moderate ability to predict post-operative adverse outcomes. The additive value of combining natriuretic peptides with an established cardiac surgical risk prediction model deserves further investigation.
